David Dorofi, MD
Otolaryngology · Norfolk, VANPI 1548261928
Payments from drug & device makers
Across 61 payments — averaging $23.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$409
- GSK$317
- Sanofi$241
- Intersect ENT, Inc.$130
- Stryker$115
- Integra Lifesciences Corporation$33
- plus $214 from 11 others
What the payments were for
- Food & beverage$1,458100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 14 | $409 |
| GSK | 18 | $317 |
| Sanofi | 9 | $241 |
| Intersect ENT, Inc. | 4 | $130 |
| Stryker | 3 | $115 |
| Integra Lifesciences Corporation | 1 | $33 |
| Medtronic | 2 | $31 |
| Genentech USA, Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $25 |
| Kaleo, Inc. | 1 | $23 |
| Hikma Pharmaceuticals USA | 1 | $20 |
| Cochlear Americas | 1 | $17 |
| Optinose US, Inc. | 1 | $17 |
| Novartis | 1 | $15 |
| Aerin Medical Inc. | 1 | $13 |
| Alk-abello, Inc | 1 | $13 |
| Conmed Corporation | 1 | $13 |
How this compares
$1,458 in reported general payments places this provider in the 50th percentile of 241 otolaryngology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $48,528 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 18 | $2,319 |
| Ipratropium Bromide | 48 | $987 |
| Azelastine Hcl | 51 | $936 |
| Fluticasone Propionate | 29 | $516 |
| Levocetirizine Dihydrochloride | 65 | $496 |
| Prednisone | 54 | $337 |
| Mometasone Furoate | 15 | $327 |
| Montelukast Sodium | 21 | $326 |
| Esomeprazole Magnesium | 12 | $276 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $89 |
| Omeprazole | 21 | $87 |
| Mupirocin | 17 | $19 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Norfolk
- Joseph HanNorfolk$2.9M
- Kent LamNorfolk$143K
- Craig DerkayNorfolk$33K
- David DarrowNorfolk$12K
- Cristina BaldassariNorfolk$8K
- Laurence OhalloranAnnandale$2.9M
- Ryan NordRichmond$482K
- Paul LenkowskiRoanoke$282K
- Nipun ChhabraLeesburg$178K
- Charles GrossCharlottesville$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.